Ralstonia pickettii infection in one patient with implantable venous access port

doi:10.3877/cma.j.issn.1674-0807.2018.06.013

Chinese Journal of Breast Disease(Electronic Edition) ›› 2018, Vol. 12 ›› Issue (06): 379-380. doi: 10.3877/cma.j.issn.1674-0807.2018.06.013

Special Issue: ；；；

• Case Report • Previous Articles Next Articles

Ralstonia pickettii infection in one patient with implantable venous access port

Xianchun Chen¹, Yinhuan Wang¹, Haiyan Fan¹

Received:2018-08-08 Online:2018-12-01 Published:2018-12-01

Abstract

Xianchun Chen, Yinhuan Wang, Haiyan Fan. Ralstonia pickettii infection in one patient with implantable venous access port[J]. Chinese Journal of Breast Disease(Electronic Edition), 2018, 12(06): 379-380.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhrxbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0807.2018.06.013

https://zhrxbzz.cma-cmc.com.cn/EN/Y2018/V12/I06/379

References 13

[1]	Fan L, Strasser-Weippl K, Li JJ，et al. Breast cancer in China[J]．Lancet Oncol，2014，15(7): e279-289.
[2]	Fischer L, Knebel P, Schröder S，et al. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients[J]. Ann Surg Oncol，2008，15(4):1124-1129.
[3]	Narducci F, Jean-Laurent M, Boulanger L，et al. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre[J]. Eur J Surg Oncol，2011，37(10):913-918.
[4]	Biffi R, de Braud F, Orsi F, et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days[J]. Ann Oncol，1998，9(7):767-773.
[5]	Wu X, Tang P, Li S, et al. A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer[J]. Nat Commun，2018，9(1):832.
[6]	Shiono M, Takahashi S, Kakudo Y，et al. Upper arm central venous port implantation: a 6-year single institutional retrospective analysis and pictorial essay of procedures for insertion[J]. PLoS One，2014，9(3):e91 335.
[7]	李海洋，黄金，高竹林，等. 完全植入式静脉输液港应用及护理进展[J]．中华护理杂志，2012，47(10):953-956.
[8]	Pandey N, Chittams JL, Trerotola SO. Outpatient placement of subcutaneous venous access ports reduces the rate of infection and dehiscence compared with inpatient placement[J]．J Vasc Interv Radiol，2013，24(6):849-854.
[9]	魏晓琳，邢鹏，李丽莉．植入式输液港与PICC在乳腺癌化疗中的应用的比较[J]．中国医科大学学报，2015，44(5):476-477.
[10]	潘小为，侯秋秀，罗金玲．植入式静脉输液港与中心静脉导管降低感染的效果比较[J]. 中华医院感染学杂志，2013，23(14): 3364-3368.
[11]	闫涛，楼正青，王丽春，等．皮氏罗尔斯顿菌医院感染的临床分析[J]．中华医院感染学杂志，2014，24(17): 4182-4184.
[12]	中心静脉通路上海协作组．完全植入式输液港上海专家共识[J]．介入放射杂志，2015，24(12):1029-1033.
[13]	Ryan MP, Pembroke JT, Adley CC. Genotypic and phenotypic diversity of Ralstonia pickettii and Ralstonia insidiosa isolates from clinical and environmental sources including high-purity Water. Diversity in Ralstonia pickettii[J]. BMC Microbiol，2011，11:194.

Please choose a citation manager

Content to export

Ralstonia pickettii infection in one patient with implantable venous access port

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References 13

Related Articles 0

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

Ralstonia pickettii infection in one patient with implantable venous access port

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References 13

Related Articles 0

Recommended Articles

Metrics

Comments